USPTO trademark

XPAC

RegisteredUSPTOWord markClass 1Class 5

"XPAC" is a word mark owned by Amunix Pharmaceuticals, Inc., filed at the USPTO on August 30, 2021. It is registered and covers classes 1 and 5.

Get this data via the API
Official USPTO record
XPAC trademark as filed
As filed with the USPTO
Status
Registered
Since April 4, 2023
Filed
August 30, 2021
Registered
April 4, 2023
Expires
Not recorded
Application no.
97002544
Registration no.
7015434
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns XPAC

The owner and representative on file with the office.

Owner

Amunix Pharmaceuticals, Inc.

South San Francisco, United States

Representative

Nicole E. Reifman

McDonnell Boehnen Hulbert & Berghoff LLP

Goods and services

What the mark covers

The products and services XPAC is filed for, grouped by Nice class.

  • Chemicals used in the manufacture of pharmaceuticals; reagents, enzymes, and nucleotides for scientific or medical research; protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; biomedical compounds, namely, peptides, peptidomimetics, and protein polymeric intermediates used in the manufacture of pharmaceutical preparations

  • Pharmaceutical preparations for the treatment of cancerous, inflammatory, immunological, and viral diseases; pharmaceutical preparations for use in the field of oncology, immunology, and inflammation for the treatment of cancer, asthma, atopic dermatitis, peripheral inflammatory diseases, cardiovascular disease, autoimmune diseases; medical diagnostic reagents; reagents for use in testing proteins for medical and diagnostic purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Teas/email correspondence entered
  8. Correspondence received in law office
  9. Teas response to office action received
  10. Notification of non-final action e-mailed

5 earlier steps on the official record.

FAQ

About XPAC

Who owns the trademark "XPAC"?

The USPTO trademark "XPAC" (application 97002544) is owned by Amunix Pharmaceuticals, Inc.

What is the status of "XPAC"?

Its status at the USPTO is: registered.

When was "XPAC" registered?

It was registered on April 4, 2023.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull XPAC and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2da7-15fd-72d6-8dfe-df22fc33ed1e
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2da7-15fd-72d6-8dfe-df22fc33ed1e",
  "object": "trademark",
  "mark_text": "XPAC",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97002544",
  "filing_date": "2021-08-30",
  "nice_classes": [
    1,
    5
  ],
  "owners": [
    {
      "name": "Amunix Pharmaceuticals, Inc.",
      "entity_id": null
    }
  ]
}